| Application no. and date | 01106315.3 (espacenet) (Federated) (European Patent Register), 19970731 | | Patent/reg. no. and date | DK/EP 1114644, 20020814 | | Publication date | 20010711 | | Priority no. and date | US 696314, 19960813 | | EP pub. no. and date |
EP 1114644 20010711 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco, CA 94080-4990, US | | Applicant ref. no. | 31061 | | Inventor | YEUNG, Douglas, A., 2628 Benchark Avenue
Fremont, CA 94536, US,
CLARK, Ross, G., 25 Glen Road
Devonport, Auckland 9, NZ,
OESWEIN, James, Q., 514 Sierra Street, PO Box 13
Moss Beach, CA 94038, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 38/30, A61P 3/10, A61K 38/28 | | Title | Præparat, som omfatter NPH-insulin (neutralt protaminhagedorn-insulin) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
